ebselen has been researched along with 1-methyl-4-phenylpyridinium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanchard, V; Daniel, N; Imperato, A; Moussaoui, S; Obinu, MC; Reibaud, M | 1 |
1 other study(ies) available for ebselen and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antioxidants; Azoles; Behavior, Animal; Blood Proteins; Callithrix; Caudate Nucleus; Disease Models, Animal; Female; Free Radicals; Glutathione Peroxidase; Herbicides; Isoindoles; Locomotion; Male; Mitochondria; Molecular Mimicry; Neurons; Neuroprotective Agents; Organoselenium Compounds; Parkinsonian Disorders; PC12 Cells; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tritium | 2000 |